NASONEX NASAL SPRAY

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Bahan aktif:

MOMETASONE FUROATE 50 MCG/DOSE

Tersedia dari:

MERCK SHARP & DOHME ISRAEL LTD

Kode ATC:

D07AC13

Bentuk farmasi:

SOLUTION

Rute administrasi :

NASAL

Diproduksi oleh:

SCHERING-PLOUGH LAB.NV BELGIUM

Kelompok Terapi:

MOMETASONE

Indikasi Terapi:

In adults and children 3 years of age and older to treat the symptoms of seasonal or perennial rhinitis. In patients 12 years old and above who have a history of moderate to severe symptoms of seasonal allergic rhinitis prophylactic treatment with Nasonex Aqueous Nasal Spary is recommended 2- 4 weeks prior to the anticipated start of the pollen season.

Tanggal Otorisasi:

2013-03-01